Diffuse large cell lymphoma
- 1 September 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 13 (5) , 325-334
- https://doi.org/10.1097/00001622-200109000-00003
Abstract
A review of new or emerging ideas concerning diffuse large B-cell lymphomas is presented, with particular emphasis on histologic classification, genetic prognostic factors, first-line and salvage treatments, and specific locations such as neurologic, cutaneous, or gastrointestinal sites. This lymphoma remains the most heterogeneous of all lymphomas for its clinical characteristics and outcome. This heterogeneity is probably secondary to the fact that a large proportion of lymphomas seems to occur from a transformation of an unknown indolent lymphoma.Keywords
This publication has 71 references indexed in Scilit:
- Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftBone Marrow Transplantation, 2000
- De Novo CD5+ Diffuse Large B-Cell LymphomasAmerican Journal of Clinical Pathology, 2000
- Primary Lymphoma of Peripheral NerveThe American Journal of Surgical Pathology, 2000
- Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b-cell non-Hodgkin's lymphomaInternational Journal of Cancer, 2000
- Human immunodeficiency virus‐associated malignant lymphoma in eastern Denmark diagnosed from 1990 to 1996: clinical features, histopathology, and association with Epstein‐Barr virus and human herpesvirus‐8European Journal of Haematology, 2000
- Allogeneic bone marrow transplantation for lymphomaBlood Reviews, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Primary intracerebral malignant lymphoma: report of 248 casesJournal of Neurosurgery, 2000
- Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphomaBone Marrow Transplantation, 2000
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993